- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Pembrolizumab – March 2015
Pembrolizumab; 50 mg injection: powder for, 1 vial, 100 mg injection: powder for, 1 vial; Keytruda®
Last updated
3 July 2015